Atlas Trials

Meningococcemia

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Meningococcemia

RecordFirmDate
Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26 (NCT00700713)Sanofi Pasteur, a Sanofi Company2008-06-01
Immunology and Safety of Menactra® in Children in Saudi Arabia (NCT00539032)Sanofi Pasteur, a Sanofi Company2007-09-01
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine (NCT00777257)Sanofi Pasteur, a Sanofi Company2005-04-01
Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents (NCT00777790)Sanofi Pasteur, a Sanofi Company2004-02-01
Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults (NCT00772629)Sanofi Pasteur, a Sanofi Company2004-01-01
Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children (NCT00771849)Sanofi Pasteur, a Sanofi Company2003-08-01
Correlation Between Cytokines and the Severity of Meningococcal Disease (NCT01133834)University of Sao Paulo General Hospital2003-03-01
Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine (NCT00772070)Sanofi Pasteur, a Sanofi Company2003-03-01

Track Meningococcemia automatically

Every clearance here is in the API, with alerts when new ones post.